[{"id":"8bc758ab-0b4b-41e5-93ef-7fefbaef118e","acronym":"","url":"https://clinicaltrials.gov/study/NCT05652855","created_at":"2022-12-15T14:58:22.186Z","updated_at":"2024-07-02T16:35:57.986Z","phase":"Phase 1/2","brief_title":"Study of MHB088C in Participants With Advanced or Metastatic Solid Tumors","source_id_and_acronym":"NCT05652855","lead_sponsor":"Minghui Pharmaceutical Pty Ltd","biomarkers":" MSI","pipe":" | ","alterations":" MSI-H/dMMR","tags":["MSI"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSI-H/dMMR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MHB088C"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 48","initiation":"Initiation: 01/23/2023","start_date":" 01/23/2023","primary_txt":" Primary completion: 01/31/2026","primary_completion_date":" 01/31/2026","study_txt":" Completion: 07/31/2026","study_completion_date":" 07/31/2026","last_update_posted":"2023-01-09"}]